Open AccessPB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW
Author(s) -
Kattamis A.,
Kwiatkowski J.,
Tricta F.,
Igboekwe E.,
Fradette C.,
Piga A.,
Sheth S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851752.44738.4e
Subject(s) - deferasirox , deferiprone , medicine , thalassemia , deferoxamine , chelation therapy , combination therapy , disease , sickle cell anemia , clinical trial , intensive care medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom